Paper32405101
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.
Demelo-Rodríguez P and 12 others. Thromb Res, 2020. Cited by 252 papers, by iCite.
Cite this record
ConductScience Library. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Papers, record 32405101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32405101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Betacoronavirus | Major topic |
| Coronavirus Infections | Major topic |
| Fibrin Fibrinogen Degradation Products | Major topic |
| Pneumonia, Viral | Major topic |
| Venous Thrombosis | Major topic |
| Anticoagulants | |
| Asymptomatic Diseases | |
| Biomarkers | |
| COVID-19 | |
| COVID-19 Testing | |
| Clinical Laboratory Techniques | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Pandemics | |
| Predictive Value of Tests | |
| Prospective Studies | |
| Risk Assessment | |
| Risk Factors | |
| SARS-CoV-2 | |
| Spain | |
| Time Factors | |
| Treatment Outcome | |
| Up-Regulation | |
| COVID-19 Drug Treatment |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32534328 | COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism? | https://conductscience.org/library/papers/32534328 |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32271988 | Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32271988 | PubMed |
| 2 | 15045125 | A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients. | Thromb Haemost | 2004 | https://conductscience.org/library/papers/15045125 | PubMed |
| 3 | 32374815 | Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. | Ann Intern Med | 2020 | https://conductscience.org/library/papers/32374815 | PubMed |
| 4 | 32353746 | Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. | Thromb Res | 2020 | https://conductscience.org/library/papers/32353746 | PubMed |
| 5 | 26298612 | Venous thromboembolism: An overview. | J Vasc Nurs | 2015 | https://conductscience.org/library/papers/26298612 | PubMed |
| 6 | 32291094 | Incidence of thrombotic complications in critically ill ICU patients with COVID-19. | Thromb Res | 2020 | https://conductscience.org/library/papers/32291094 | PubMed |
| 7 | 32311448 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2020 | https://conductscience.org/library/papers/32311448 | PubMed |
| 8 | 32220112 | Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32220112 | PubMed |
| 9 | 32126379 | Predictive value of D-dimer testing for the diagnosis of venous thrombosis in unusual locations: A systematic review. | Thromb Res | 2020 | https://conductscience.org/library/papers/32126379 | PubMed |
| 10 | 32278361 | Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. | Lancet Haematol | 2020 | https://conductscience.org/library/papers/32278361 | PubMed |
| 11 | 28549662 | Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. | Lancet | 2017 | https://conductscience.org/library/papers/28549662 | PubMed |
| 12 | 22694877 | Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting. | Thromb Res | 2012 | https://conductscience.org/library/papers/22694877 | PubMed |
| 13 | 32178975 | Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. | Clin Chim Acta | 2020 | https://conductscience.org/library/papers/32178975 | PubMed |
| 14 | 11453709 | Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. | Ann Intern Med | 2001 | https://conductscience.org/library/papers/11453709 | PubMed |
| 15 | 32246450 | D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. | Thromb Haemost | 2020 | https://conductscience.org/library/papers/32246450 | PubMed |
| 16 | 32109013 | Clinical Characteristics of Coronavirus Disease 2019 in China. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32109013 | PubMed |
| 17 | 24643601 | Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. | JAMA | 2014 | https://conductscience.org/library/papers/24643601 | PubMed |
| 18 | 19008109 | Thromboembolic disease after total knee replacement: experience of 5100 cases. | Knee | 2009 | https://conductscience.org/library/papers/19008109 | PubMed |
| 19 | 31774957 | Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31774957 | PubMed |
| 20 | 32369666 | Incidence of venous thromboembolism in hospitalized patients with COVID-19. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32369666 | PubMed |
Cited by210
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 252 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42438485 | Arterial and venous thromboembolism in hospitalized patients with COVID-19: a national multicenter cohort study. | Blood Vessel Thromb Hemost | 2026 | https://conductscience.org/library/papers/42438485 | PubMed |
| 41458994 | Scoping review about pathogenesis, risk factors, and treatment of venous and arterial thrombosis in coronavirus infection. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41458994 | PubMed |
| 41149067 | Thrombophilic Changes and Hematological Complications in Asthmatic Patients with COVID-19: A Systematic Review. | Diseases | 2025 | https://conductscience.org/library/papers/41149067 | PubMed |
| 40682057 | Utility of lower extremity ultrasound prior to application of serial compression device in patients with COVID-19: "choosing wisely" initiative at a major referral center in the Middle East. | Thromb J | 2025 | https://conductscience.org/library/papers/40682057 | PubMed |
| 40106444 | Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin. | PLoS One | 2025 | https://conductscience.org/library/papers/40106444 | PubMed |
| 40044746 | Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry. | Sci Rep | 2025 | https://conductscience.org/library/papers/40044746 | PubMed |
| 39816043 | Age and clinical spectrum of COVID-19 are associated with safety of transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study. | J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/39816043 | PubMed |
| 39286300 | Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery. | J Vasc Bras | 2024 | https://conductscience.org/library/papers/39286300 | PubMed |
| 39239073 | Diabetic peripheral arterial disease in COVID-19 pandemic. | J Res Med Sci | 2024 | https://conductscience.org/library/papers/39239073 | PubMed |
| 39157833 | Role of C-reactive protein, IL-6, and D-dimers in prediction of severity of coronavirus disease 2019: A pilot study. | J Oral Maxillofac Pathol | 2024 | https://conductscience.org/library/papers/39157833 | PubMed |
| 39078534 | Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021-2022. | J Thromb Thrombolysis | 2024 | https://conductscience.org/library/papers/39078534 | PubMed |
| 38933992 | Guidance for clinical practice using emergency and point-of-care ultrasonography. | Acute Med Surg | 2024 | https://conductscience.org/library/papers/38933992 | PubMed |
| 38620815 | Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis. | Thromb Update | 2021 | https://conductscience.org/library/papers/38620815 | PubMed |
| 38620680 | Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients. | Thromb Update | 2021 | https://conductscience.org/library/papers/38620680 | PubMed |
| 38620598 | Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels. | Thromb Update | 2021 | https://conductscience.org/library/papers/38620598 | PubMed |
| 38146412 | Prevalence of Thromboembolic Events, Including Venous Thromboembolism and Arterial Thrombosis, in Patients with COVID-19: A Systematic Review with Meta-Analysis. | J Tehran Heart Cent | 2023 | https://conductscience.org/library/papers/38146412 | PubMed |
| 37840687 | COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/37840687 | PubMed |
| 37762435 | Crosstalk between Platelets and SARS-CoV-2: Implications in Thrombo-Inflammatory Complications in COVID-19. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762435 | PubMed |
| 37583776 | D-dimer Levels in Predicting Severity of Infection and Outcome in Patients with COVID-19. | Tanaffos | 2022 | https://conductscience.org/library/papers/37583776 | PubMed |
| 37554128 | Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37554128 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| F5 | 2153 | PubTator's text mining | https://conductscience.org/library/genes/2153 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32405101
GET https://conductscience.org/api/papers/v1/32405101/cited_by?page=2